Overview

HF Assessment With BNP in the Home: Part II

Status:
Terminated

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

HABIT-II is a feasibility study aimed at home monitoring of patients with heart failure. B-type natriuretic peptide (BNP) has strong correlations to the severity of heart failure. Lower BNP levels are closely associated with better clinical outcomes. The goal of HABIT-II is to demonstrate that the results of daily patient self-testing of BNP at home will provide sufficient information to guide physicians to modify therapy and lower BNP levels over time.

Phase:

N/A

Details

Lead Sponsor:

Alere San Diego

Treatments:

Angiotensin II
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Mineralocorticoid Receptor Antagonists